Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2005
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276812 Antibody-drug conjugates and methods
12/15/2005US20050276811 Natural IgM antibodies and inhibitors thereof
12/15/2005US20050276807 Treatment of acne
12/15/2005US20050276806 Treatment of autism
12/15/2005US20050276805 Antibody molecules having a Fc region with complex N-glycoside-linked sugar chains bound it through an N-acetylglucosamine of the reducing terminal of the sugar chains, which do not contain chains with a fucose bound to the N-acetylglucosamines.
12/15/2005US20050276804 Method for preventing or treating cardiac hypertrophy
12/15/2005US20050276803 Method for augmenting B cell depletion
12/15/2005US20050276802 Comprising a variable heavy (VH) domain that has non-human hypervariable region residues incorporated into a human VH domain, said variable domain comprising a framework region (FR) substitution; anticarcinogenic agents, angiogenesis inhibitors; immunoaffinity chromatography, immunoassay; containers
12/15/2005US20050276801 Method of treatment using humanized anti-CD11a antibodies
12/15/2005US20050276800 Intrabodies
12/15/2005US20050276799 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
12/15/2005US20050276798 with a histidine buffer and maltose; anti-HIV; higher concentrations, are storage stable, compatible with lyophilization, and safe to administer by intravenous injection
12/15/2005US20050276797 Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
12/15/2005US20050276756 Compositions as adjuvants to improve immune responses to vaccines and methods of use
12/15/2005CA2776050A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2775886A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2572451A1 Annexin a1 based vascular targets for detecting, imaging and treating neoplasia or neovasculature
12/15/2005CA2572348A1 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
12/15/2005CA2569509A1 Anti-cd3 antibodies and methods of use thereof
12/15/2005CA2569240A1 Drug fusion comprising a polypeptide drug and an immunoglobulin heavy chain variable domain specific for serum albumin
12/15/2005CA2568998A1 Polypeptides having dna polymerase activity
12/15/2005CA2568838A1 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005CA2568780A1 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005CA2568162A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2567728A1 Griffithsin, glycosylation-resistant griffithsin, and related conjugates,compositions, nucleic acids, vectors,host cells, methods of production and methods of use
12/15/2005CA2567655A1 Binding moieties based on shark ignar domains
12/15/2005CA2567526A1 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005CA2567520A1 Maytansinoid-antibody conjugates
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2566979A1 Use of a cd20 antibody in treatment of multiple sclerosis
12/15/2005CA2566975A1 Method to reduce hepatotoxicity of fas-mediated apoptosis-inducing agents
12/15/2005CA2565827A1 Bispecific binding agents for modulating biological activity
12/15/2005CA2564529A1 Preventing autoimmune disease
12/15/2005CA2564098A1 Solution phase biopanning method using engineered decoy proteins
12/15/2005CA2564092A1 Methods and compositions for the treatment of polycystic diseases
12/15/2005CA2563445A1 Compositions and methods for modulating vascular development
12/15/2005CA2562771A1 Anti-il-9 antibody formulations and uses thereof
12/15/2005CA2561861A1 Antibodies to angiogenesis inhibiting domains of cd148
12/15/2005CA2561823A1 Antibodies of angiogenesis inhibiting domains of cd148
12/14/2005EP1605263A2 Methods, composition and kit for measuring expression of a cell-surface
12/14/2005EP1605061A1 Neisseria genomic sequences and methods of their use
12/14/2005EP1605058A1 Method of screening light chain of antibdoy
12/14/2005EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605049A2 Fibrinolytically active polypeptide
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1604997A1 Human polyclonal antibodies from transgenic nonhuman animals
12/14/2005EP1604996A2 An allergenic protein complex of natural rubber latex
12/14/2005EP1604668A1 Hepoxilins and modulators of ichthyin for treating skin disorders
12/14/2005EP1604032A2 Method for detecting prognosis of cancer
12/14/2005EP1603949A2 Antibodies against human il-21 receptor and uses therefor
12/14/2005EP1603948A1 Antibodies to igf-i receptor for the treatment of cancers
12/14/2005EP1603947A1 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (par1)
12/14/2005EP1603941A1 Inhibitors of extracellular hsp90
12/14/2005EP1603592A2 Therapeutical use of anti-myelin associated glycoprotein (mag) antibodies
12/14/2005EP1603587A1 Use of tumor endothelial markers 1, 9 and 17 to promote angiogenesis
12/14/2005EP1603585A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1414859B1 Anti-ssrp-1 monoclonal antibodies and hybridomas producing said antibodies
12/14/2005EP1326895B1 Monoclonal antibodies directed against hepatitis b viruses
12/14/2005EP1280904B1 Pain signaling molecules
12/14/2005EP1178821B1 Use of anti-hbp antibodies in the inhibition of bradykinin release
12/14/2005EP1177292B1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1080198B1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/14/2005EP1015494B1 Method of producing catalytic antibodies
12/14/2005EP1007666B1 Neurturin receptor
12/14/2005EP0952219B1 Recombinant fusion proteins of the porcine reproductive and respiratory syndrome virus (PRRSV) and its use in diagnosis
12/14/2005EP0931146B1 Rdgb-proteins
12/14/2005EP0927045B1 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/14/2005EP0858504B1 Diagnostics and treatments of periodontal disease
12/14/2005CN1708506A Polysaccharide vaccine for staphylococcal infections
12/14/2005CN1708317A Combination therapy with class III anti-CEA monoclonal antibodies and therapeutic agents
12/14/2005CN1706866A Rice stripe virus monoclonal antibody and rice stripe virus immunodetecting method
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231497C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
12/14/2005CN1231496C Human protein with cancer cell growth suppressing function and its coding sequence
12/14/2005CN1231264C Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974860 Target recognizing binding agents
12/13/2005US6974689 Nucleic acid encoding PRO211 polypeptides
12/13/2005US6974573 Antibody production in farm animals
12/13/2005US6974572 Peptide for use in the treatment of allergic disorders
12/13/2005CA2001328C Borrelia antigen
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116655A2 Natriuretic compounds, conjugates, and uses thereof
12/08/2005WO2005116645A2 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers
12/08/2005WO2005116270A2 Influenza virus vaccine composition and method of use
12/08/2005WO2005116251A1 Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis
12/08/2005WO2005116236A2 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna
12/08/2005WO2005116080A1 Antibody specific for alkylphenol and use thereof
12/08/2005WO2005116079A1 Antibody capable of recognizing ligand of allylhydrocarbon receptor and use thereof
12/08/2005WO2005116078A1 Glycosylated immunoglobulin and immunoadhesin comprising the same
12/08/2005WO2005116077A2 LIGANDS BINDING THE COMPLEX OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (uPA) AND ITS RECEPTOR (uPAR) THAT INHIBIT DOWNSTREAM uPAR INTERACTIONS: IDENTIFICATION AND USE IN DIAGNOSIS OR THERAPY
12/08/2005WO2005116076A2 Neoplasm-specific polypeptides and their uses
12/08/2005WO2005116072A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/08/2005WO2005116071A2 Snares for pathogenic or infectious agents and uses related thereto
1 ... 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 ... 1494